Real Diagnostics Acquires SimplyTest for Saliva-Based Oral Health Testing

Real Diagnostics has acquired SimplyTest, expanding its laboratory portfolio with saliva-based oral health diagnostic testing, according to PR Newswire and Pulse2.

PR Newswire identified Real Diagnostics as a CLIA-certified clinical laboratory specializing in high-complexity molecular infectious disease and toxicology testing. Pulse2 described SimplyTest as a provider of saliva-based oral health diagnostic tests.

Portfolio expands into oral health

PR Newswire reported that the acquisition expands Real Diagnostics’ high-complexity laboratory portfolio with saliva-based oral health testing. Pulse2 likewise reported that the transaction expands the company’s molecular diagnostic services into this testing area.

According to Pulse2, the acquisition adds periodontal health testing to the Real Diagnostics laboratory portfolio. The publisher also reported that the transaction establishes a new service offering for dental practices.

Testing focus joins existing laboratory services

The reported acquisition brings SimplyTest’s saliva-based oral health diagnostic tests into a laboratory organization focused on high-complexity molecular infectious disease and toxicology testing, as described by PR Newswire.

Pulse2 characterized the development as an expansion into saliva-based oral health testing and periodontal health testing. PR Newswire similarly framed the transaction as an expansion of Real Diagnostics’ high-complexity laboratory portfolio.

Relevance for diagnostics and laboratory sales

For medical diagnostics and laboratory sales professionals, the acquisition centers on a portfolio addition involving saliva-based oral health testing. The published reports identify periodontal health testing and dental practices as part of the expanded offering described by Pulse2.

The two reports also place the transaction within Real Diagnostics’ broader laboratory activity. PR Newswire noted the company’s specialization in high-complexity molecular infectious disease and toxicology testing, while Pulse2 reported the addition of saliva-based oral health diagnostic testing through SimplyTest.

PR Newswire and Pulse2 each reported the acquisition of SimplyTest by Real Diagnostics. Their coverage describes the transaction as a move that broadens the laboratory portfolio into saliva-based oral health testing, including periodontal health testing and a service offering for dental practices.